# NEXT_SESSION.md — Session 85 Handoff
**Written:** 2026-05-27  
**Last commit:** `2c889eda61e3` (Session 83 — competitive_relevance + relevance_rationale restored in DCS)  
**Last DB change:** Session 84 — `disease_areas` dropped (no code commit)

---

## Session 84 Complete: disease_areas DB Retirement

`disease_areas` is fully retired from Supabase:

- **13 FK constraints** dropped automatically via `DROP TABLE public.disease_areas CASCADE`
- Table no longer exists (`table_exists = false`, `remaining_fks = 0`)
- Dashboard behavior unchanged — zero console errors, all 4 area tabs + OEX validated
- No code change needed — all reads were cleaned in Session 80

Retirement doc written: `docs/disease_areas_db_retirement_execution.md`

---

## Session 83 Complete: competitive_relevance Restored

Option C executed — `competitive_relevance` + `relevance_rationale` added to `drug_competitive_scores`, backfilled (166 rows), and activated in `_makeAreaPI` DCS select. Strategic relevance layer is live in production.

---

## Retirement Status Summary

| Table | Status | Next Step |
|---|---|---|
| `disease_areas` | **✅ RETIRED** | Done — dropped Session 84 |
| `drug_area_scores` | **🟡 Near-ready** | Dual-read harness decommission gate: 2026-06-27 (30 days from Session 83) |
| `drug_areas` | **🔴 Blocked** | Active fallback in `_makeAreaPI` for il4ra/tslp/ted until Phase 5 activations |
| `area_metadata` | **✅ Keep permanently** | Migration tracking system |
| `legacy_area_ontology_map` | **✅ Keep permanently** | Bridge table for all Phase 3+ backfills |

### area_metadata current state

| area_id | retirement_status | Note |
|---|---|---|
| atopy | flag_activated | Phase 3 done |
| fcrn | flag_activated | Phase 3 done |
| igf1r | flag_activated | Phase 3 done |
| tl1a | flag_activated | Phase 3 done |
| ibd | flag_activated | Phase 3 done |
| il4ra | legacy_retained | biological reads still on drug_area_scores pending Phase 5 activation |
| ted | legacy_retained | biological reads still on drug_area_scores pending Phase 5 activation |
| tslp | legacy_retained | biological reads still on drug_area_scores pending Phase 5 activation |
| autoimmune | not_started | Preserved strategic view |
| respiratory | not_started | Preserved strategic view |
| tcell | not_started | Preserved platform view |

---

## Session 85 Options

No P0 mandate. Three independent tracks:

### Track A — 87 null competitive_relevance rows (enrichment)

87 DCS rows (drugs added after the original DAS migration) have `competitive_relevance = null`. They show no badge/border — correct behavior for un-enriched entries.

To identify:
```sql
SELECT dcs.drug_id, dcs.context_id, d.name
FROM drug_competitive_scores dcs
LEFT JOIN drugs d ON d.id = dcs.drug_id
WHERE dcs.competitive_relevance IS NULL
ORDER BY dcs.context_id, d.name;
```

Fill by running `company_enrichment.py` against those drugs for their respective areas. The enrichment pipeline produces `competitive_relevance` as part of normal output.

### Track B — Dual-read harness decommission review

Earliest eligible: **2026-06-27** (30 days from Session 83 competitive_relevance activation).

The five harnesses (`_runPhase4BDualRead`, `_runPhase4BTL1ADualRead`, `_runPhase4BTEDDualRead`, `_runPhase4BAtopyDualRead`, `_runPhase4BFcRNDualRead`) compare DCS vs DAS `overlap` tiers. Do not decommission before the gate date.

### Track C — Phase 5 activations for il4ra / tslp / ted

These three areas are still reading biological drug data from `drug_area_scores` (legacy) rather than the ontology pipeline. Activating them would:
1. Unblock `drug_areas` retirement
2. Complete the full Phase 5 migration

Pre-flight required before any activation: count/overlap/classify audit (see `project_phase5_inflection.md`).

---

## Session 85 Constraints

Do NOT:
- Touch `drug_area_scores`
- Remove dual-read harnesses before 2026-06-27
- Drop `drug_areas`

---

## Known Good State

- Dashboard: live at GitHub Pages, commit `2c889eda61e3`
- `disease_areas`: **DROPPED from Supabase**
- `drug_competitive_scores`: 253 rows — 166 with `competitive_relevance`, 87 null (enrichment queue)
- `drug_area_scores`: archival only — dual-read harness baseline, no production UI reads
- `drug_areas`: active fallback for il4ra/tslp/ted pending Phase 5 activation
- Phase 3 dual-filter: all 4 reads on `target_id OR area_id`
- Partner pill system: all known issues resolved
- Zero console errors across all tabs
